LEADERSHIP

MISSION IN MOTION

We believe meaningful leadership is based on trust, integrity, communication and, above all, action. Our leadership team strives to continually connect and collaborate with our customers, our employees and our partners to understand the ever-changing dynamics facing healthcare providers today. We empower our team to collaborate to solve challenges with passion and dedication. By understanding every individual’s contribution is essential to achieving excellence, delivering the science, innovation and care that every patient deserves.

EXECUTIVE LEADERSHIP TEAM

Our management team’s experience is rooted in the global medical device industry. Their knowledge spans the entire product life-cycle across a variety of disease states and therapies. Their passion and proven track record for driving consistent growth is essential to our company’s success.

Nestor Jaramillo, Jr.

President & Chief Executive Officer

More

Nestor Jaramillo, Jr. has been a key player in medical device commercialization for more than 20 years and has led commercial organizations in both startup and multinational companies.

Prior to joining CHF Solutions (now Nuwellis), Mr. Jaramillo was president and CEO of Innerspace Neuro Solutions, Inc., a Tustin, Calif.-based commercial-stage medical technology company that developed, manufactured, and distributed an intracranial pressure monitoring system. He also worked in a variety of capacities at startup Transoma Medical, St. Jude Medical, and Medtronic.

In addition, Mr. Jaramillo also spent seven years as a managing director of healthcare investment banking at both Cherry Tree & Associates and Craig-Hallum Capital, both in Minneapolis.

Mr. Jaramillo holds an electrical engineering degree from the University of North Dakota and a Master of Business Administration from the University of St. Thomas in Minneapolis.

George Montague

Chief Financial Officer

More

George Montague joined Nuwellis in June 2021 as Chief Financial Officer.  George’s prior experience in the medical-device sector includes Chief Operating Officer and Chief Financial Officer with Smiths Medical, and Vice President of Finance and Strategy with Medtronic’s Restorative Therapies Group and its Diabetes division.  Broader technology industry experience includes financial leadership positions with Cisco Systems, Hughes Electronics, and Apple.

Mr. Montague received a Bachelor of Science in Business Administration from the University of California at Berkeley, and a Master of Business Administration from The Wharton School at the University of Pennsylvania. He is also a Chartered Financial Analyst and Certified Public Accountant.

Neil P. Ayotte

General Counsel and Chief Compliance Officer

More

Neil P. Ayotte, Esq. joined Nuwellis as Senior Vice President, General Counsel, Secretary, and Chief Compliance Officer in June 2021. With over 30 years of experience as a lawyer and business leader, Mr. Ayotte has devoted more than 16 years to the medical device industry. Prior to joining Nuwellis, Mr. Ayotte was Executive Vice President, Secretary, and General Counsel of Bluestem Group, Inc., a publicly-traded online retailer with over $1 billion in sales. Before joining Bluestem, Mr. Ayotte worked with Medtronic plc, the world’s largest medical device company, where he served in positions of increasing responsibility including Vice President of Corporate & Securities, Deputy General Counsel, Interim General Counsel, and Chief Counsel of the Americas Region, the largest of Medtronic’s four super regions. Earlier in his career, Mr. Ayotte was a partner in the corporate law department of the Minneapolis-based Maslon law firm.

Mr. Ayotte received his law degree from the University of Minnesota, a master’s degree from the University of Wisconsin, and a bachelor’s degree from St. Mary’s University of Minnesota, summa cum laude.

Sandra Eayrs

Senior Vice President of Human Services

More

Sandra Eayrs joined CHF Solutions (now Nuwellis) in 2014 as Director of Human Resources and was appointed to VP of Human Resources in 2015. She is responsible for all aspects of human resources management for the organization and is an advisor to the leadership team in advancing organization capabilities and effectiveness.

Sandra brings more than 20 years of human resources experience in the medical device and other high-tech manufacturing industries. She has held various HR roles with increasing levels of responsibility within Rosemount, Graco, Boston Scientific, and most recently, St. Jude Medical. Additionally, Sandra launched a successful consulting practice utilizing her extensive HR experience and business acumen to consult with multiple clients from small to large Fortune 500 companies in a variety of industries.

Mrs. Eayrs received a Business Administration degree from the University of Wisconsin.

William Colón

Vice President of Sales & Marketing

More

William Colón joined CHF Solutions (now Nuwellis) in July of 2019 as Vice President of Marketing, a position he held until January 2021 when he was promoted to Vice President of Sales & Marketing.

Prior to joining Nuwellis, Mr. Colón spent 17 years at Medtronic, plc, a global leader in the medical device industry, where he held positions of increasing responsibility in marketing, culminating in multiple senior marketing leadership positions in the Cardiovascular Group. As a high-impact global executive, Mr. Colón developed new global markets and led high-performing teams to accomplish organizational goals, develop emerging technologies, execute global product launches, and achieve sales expectations.

Mr. Colón graduated with a BSE in electrical engineering from the University of Michigan and holds an MBA in marketing and corporate strategy from the Ross School of Business at the University of Michigan.

Laurent Duhoux

Vice President of International Business Development

More

Mr. Duhoux spent 7 years with Edwards Lifesciences in several senior marketing and sales positions, launching new products and building the European market for those products. Prior to his Edwards experience, Mr. Duhoux spent 18 years with Gambro Renal Products, with the last four years as Vice President of the Intensive Care Business.

Mr. Duhoux is fluent in English, French, German, Spanish, and Portuguese. He holds a Master’s Degree in Biomedical Engineering from the University of Lyon, France, and an executive MBA from EM Lyon Business School.

Vitaliy Epshteyn

Senior Vice President of Operations & Engineering

More

Vitaliy Epshteyn joined CHF Solutions (now Nuwellis) in January of 2018 as Vice President of Operations and Engineering. Prior to joining Nuwellis, Mr. Epshteyn was Chief Technology Officer and Senior Director of Engineering for TE Connectivity’s Medical Business Unit. TE Connectivity is a company focused on providing interconnect and interventional solutions to key medical OEMs. Mr. Epshteyn was instrumental in leading organic and inorganic business strategies for TE Connectivity, resulting in rapid revenue growth. TE Connectivity successfully acquired and integrated AdvancedCath Inc and Creganna Medical during Mr. Epshteyn’s tenure.

Prior to TE Connectivity, Mr. Epshteyn held several leadership roles at St. Jude Medical (now Abbott), a company focused on treating heart failure, structural heart, vascular, and neurological diseases. In his role as Site Leader and Senior Research and Development Director for CRM Division in Minnesota, Mr. Epshteyn was responsible for the rapid development and commercialization of several key product lines including CRM lead delivery tools, electromagnetic navigation system, and renal denervation ablation catheter and generator.

Mr. Epshteyn holds two US patents for manufacturing methods and medical device development. He earned his Bachelor of Chemical Engineering from the University of Minnesota and holds an MBA from the University of St. Thomas.

David Lerner

Chief Technology Officer

More

Mr. Lerner has held executive product and organizational development leadership roles at medical diagnostic device firms. Most recently, he was at Senseonics, Inc. as the Vice President of Engineering. Prior to that, he was Chief Technology Officer at Biomedix where he led the company’s development of hardware, software, and web-based service solutions for the management of patients with vascular disease. Mr. Lerner was a co-founder and board member of Biomedix and served as the VP of Engineering from 1997 to 2002. During this time, he was instrumental in helping to develop the company’s original product line, including the Portable Vascular Lab, which has evolved into one of the company’s flagship products, PADnet™.

Mr. Lerner has also served as VP of Engineering and Technology for Image Sensing Systems, Inc. and Telex Communications, Inc. where he directed technical activity at multiple domestic and international locations with a strong focus on innovation and on-time delivery. He is the recipient of several device design patents and holds a BS in Electronics Engineering from the State University of New York, as well as an MS in Management and MS in Medical Physics from the University of Minnesota.

Al Saalabi

Vice President of Quality and Regulatory

More

Al Saalabi joined Nuwellis in July 2021 as the Vice President of Quality and Regulatory. Mr. Saalabi has over 20 years of experience building world-class quality and regulatory teams and capabilities across the U.S., Europe, and Asia for medical device companies. Prior to joining Nuwellis, he was President and Chief Consultant for Med Dev Global Solutions, quality and regulatory service consultancy focusing on the medical device industry. His experience also includes 12 years at ACIST Medical Systems (a subsidiary of Bracco Group) that specializes in manufacturing state-of-the-art contract injection systems, where he served as the VP of Quality and Regulatory. Prior to ACIST, Mr. Saalabi spent 8 years at Mentor Corporation (now a part of Johnson & Johnson), a leading supplier of aesthetics, as VP of Quality and Regulatory Affairs.

Mr. Saalabi Graduated with a BSE in Electrical Engineering from Kingston University U.K and a master’s degree in electrical engineering (MSEE) from the University of Southern California (U.S.C) in Los Angeles.

BOARD OF DIRECTORS

Our Board of Directors is comprised of medical device, clinical practice and investment industry veterans from leading organizations around the globe. Their vast and diverse expertise serves as a guide to drive our company’s vision and value.

John Erb

Chairman of the Board

More

John Erb has served as chief executive officer and president of the Company since November 2015, as a director of the Company since September 2012, and as Chairman of the Board since October 2012. Mr. Erb has over 40 years of experience in the medical device industry, executive leadership, and financial management.

Previously, Mr. Erb served as chief executive officer (from 2007 to 2018) of NuAx, Inc. (formerly Cardia Access, Inc.), a medical device company involved in developing new devices for the treatment of heart disease; he was executive chairman of the board (during 2007) and chief executive officer (from 2001 to 2006) of the previous owner of the Aquadex FlexFlow System, which was also known as CHF Solutions, Inc. (now Nuwellis), a medical device company involved in the development, manufacturing and distribution of devices to treat congestive heart failure; as president and chief executive officer of IntraTherapeutics, Inc., a medical device company involved in the development, manufacturing and distribution of peripheral vascular stents, from 1997 to 2001; and in various positions, including as vice president of worldwide operations at Schneider, a division of Pfizer, Inc., from 1991 to 1997.

Mr. Erb serves as Chairman of the Board of Directors for Osprey Medical, a public Australian company listed on the ASX. Mr. Erb previously served on the Board of Directors of Vascular Solutions (acquired by Teleflex in 2017), SenoRx, Inc. (acquired by CR Bard in 2010), and CryoCath Technologies (acquired by Medtronic in 2008).

Mr. Erb has a B.A. degree in Business Administration from California State University, Fullerton.

Nestor Jaramillo, Jr.

Executive Member

More

Nestor Jaramillo, Jr. has been a key player in medical device commercialization for more than 20 years and has led commercial organizations in both startup and multinational companies.

Prior to joining CHF Solutions (now Nuwellis), Mr. Jaramillo was president and CEO of Innerspace Neuro Solutions, Inc., a Tustin, Calif.-based commercial-stage medical technology company that developed, manufactured, and distributed an intracranial pressure monitoring system. He also worked in a variety of capacities at startup Transoma Medical, St. Jude Medical, and Medtronic.

In addition, Mr. Jaramillo also spent seven years as a managing director of healthcare investment banking at both Cherry Tree & Associates and Craig-Hallum Capital, both in Minneapolis.

Mr. Jaramillo holds an electrical engineering degree from the University of North Dakota and a Master of Business Administration from the University of St. Thomas in Minneapolis.

Steve Brandt

Non-Executive Member

More

Mr. Brandt is a senior executive with over 35 years of experience in the healthcare industry. Mr. Brandt was employed by Thoratec Corporation from November 2004 to October 2015, serving as Vice President Global Sales and Marketing, Vice President of Global Sales, and Vice President International Sales. Prior to Thoratec, Mr. Brandt was Vice President Sales & Marketing for CHF Solutions (now Nuwellis) from October 2002 to November 2004 and Vice President Global Marketing, Cardiovascular Surgery Division for St. Jude Medical from November 2000 to October 2002.

Mr. Brandt received his B.S. from Franklin Pierce College.

Maria Rosa Costanzo, M.D.

Non-Executive Member

More

Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and the medical director for Advanced Heart Failure at Edward Hospital Center in Illinois. She currently serves on the board of directors for the Heart Failure Society of America. In addition, she is a member of several medical societies and a fellow with the American College of Cardiology, American College of Physicians, American Heart Association, and the European Society of Cardiology, and a Gold Member of the Heart Failure Association of the European Society of Cardiology. Dr. Costanzo has over 250 publications in peer-reviewed journals, book chapters, and manuscripts. She received her medical degree with honors from Facolta’ Di Medicina e Chirurgia dell’ Universita’ di Bologna, Bologna, Italy.

Jon Salveson

Non-Executive Member

More

Jon Salveson is the Vice Chairman, Investment Banking, and Chairman of the Healthcare Investment Banking Group at Piper Jaffray. Mr. Salveson joined Piper Jaffray in 1993 and became a Managing Director in 1999. He was named the Group Head of Piper Jaffray’s healthcare investment banking group in 2001.

He then was appointed Global Head of Investment Banking and a member of the Executive Committee of Piper Jaffray in 2004. He has served as Vice Chairman of Investment Banking at Piper Jaffray since 2010. Throughout his career at Piper Jaffray, Mr. Salveson’s area of practice has focused on the medical device industry.

Mr. Salveson started his career as a market manager at Bio-Metrics Systems (now part of Surmodics, Inc), an innovator in medical device surface modification, where he gained experience working in cardiology and interventional medicine. Currently, he serves on the Board of Directors at the Minnesota Orchestra since 2007 and CyroLife Inc. since 2012. In addition, he serves on the Board of Regents for St. Olaf College since 2011.

Mr. Salveson received his M.M.M. in finance from the Kellogg Graduate School of Management at Northwestern University and a B.A. in chemistry and religion from St. Olaf College.

Greg Waller

Non-Executive Member

More

Mr. Waller has over 35 years of financial and management experience with an emphasis in financial management, accounting, treasury, and mergers/acquisitions. He was Chief Financial Officer of Universal Building Products, a manufacturer of concrete construction accessories, from March 2006 until April 2011 where he implemented several cost savings initiatives that saved the company several million dollars. Previous to this position, he had been in retirement except for board of director positions. Prior, Mr. Waller served as the Chief Financial Officer, Vice President of Finance, and Treasurer of Sybron Dental Specialties, Inc., a manufacturer and marketer of consumable dental products. At Sybron he was instrumental in a variety of initiatives including being instrumental in the IPO of the company, over 30 company acquisitions worldwide and sales growth from $10 million to over $750 million during his twenty-five-year tenure at Sybron. He was the Vice President of European Operations for Kerr (a subsidiary of Sybron) and Vice President and Controller at Ormco (also a subsidiary of Sybron) during his time at Sybron. Mr. Waller has an MBA with a concentration in accounting from California State University, Fullerton.

Mr. Waller currently serves as a board member and audit committee chairman for Endologix, Inc. He previously served as a board member and audit committee chairman for Alsius, Inc., Biolase, Inc., Cardiogenesis Inc., Clarient, Inc. and SenRx, Inc., all publicly traded companies.

Warren Watson

Non-Executive Member

More

Mr. Watson is a medical device executive with over 35 years of experience. His career began with Medtronic, Inc. where he served in roles of increasing responsibility. Mr. Watson focused on cardiac rhythm management, cardiac ablation, heart failure, and cardiology including positions in technical management, clinical and regulatory, business development, strategy and marketing, and general management. He served as VP of R&D for the Cardiac Rhythm Management business for over 8 years and was Chair of the Medtronic Corporate Research and Development Council. Mr. Watson retired from Medtronic after 33 years of service. Following his retirement, he has served on multiple medical device, non-medtech, and charitable organization Boards:

  • Executive Chair of the Board of Directors for Cameron Health, Inc.
  • Board of Directors for Cardia Access, Inc., an early-stage medtech company developing innovative technology for endocardial cardiac leads.
  • Board of Directors for Cardialen, Inc., an early-stage medtech company developing unique, non-ablative technology for the termination of atrial fibrillation.
  • Advisor to the Office of Technology Commercialization at the University of Minnesota, working closely with the Venture Center to launch medical device companies based on U of MN Innovation.
  • Board of Gillette Children’s Specialty Healthcare in St. Paul, MN.
  • Board of Directors of Citizen’s Independent Bank, a community-based bank in the Twin Cities with four branch offices and over $300MM in assets.

Mr. Watson is a graduate of the University of Minnesota with undergraduate and graduate degrees in Electrical Engineering.

MEDICAL ADVISORY BOARD

Our Medical Advisory Board is comprised of physicians, surgeons, scientists and faculty from leading institutions world-wide. Each member brings a unique perspective to improving outcomes for patients suffering from fluid overload.

Daniel Beckles

MD, PhD, FACS

More

Dr. Daniel Beckles is a senior cardiothoracic surgeon at Baylor Scott & White Health in Central Texas. He obtained his MD degree from SUNY Downstate Medical School in Brooklyn NYC and stayed there for his Ph.D. in Cardiovascular Molecular and Cell Biology and General Surgery residency. His Cardiothoracic Surgery residency was at UT Southwestern Medical Center in Dallas. He spent an additional year at the Brigham & Women’s Hospital-Instructor of Surgery at Harvard Medical School before his first attending position at Mount Sinai Medical Center in NYC. He spent 5 years at UT Medical Branch in Galveston Texas and was then Chief of Cardiothoracic Surgery at Downstate Medical Center in Brooklyn, NYC.

Dr. Beckles has published in textbooks, peer-reviewed journals, and has 2 US patents on heart diseases. His focus is on clinical excellence, education, and research. His expertise is in the management of end-stage heart disease, multiorgan failure, and surgical leadership. He is double boarded by the American Board of Surgery and the American Board of Thoracic Surgery.

Dr. Beckles is the Chief Medical Officer (CMO) of Trinbago Progressive Association, President-elect of the SUNY Downstate Alumni Board of Managers, Advisor for Noigel, and consultant for CHF Solutions (now Nuwellis) and Edwards Lifesciences.

Steven Coca

DO, MS

More

Dr. Steven G. Coca is a graduate of the University of New England College of Osteopathic Medicine. He completed his medical residency and clinical nephrology fellowship at Yale University and Yale-New Haven Hospital in Connecticut. He also received a Master’s Degree in Epidemiology and Public Health during his training at Yale, later serving as an Assistant Professor in the Section of Nephrology until his recruitment to Mount Sinai in 2014 as Associate Professor. Currently, Dr. Coca is the Director for Clinical Research for the Division of Nephrology and is the Associate Chair for Clinical and Translational Research for the Department of Medicine at the Icahn School of Medicine at Mount Sinai.

Dr. Coca’s research has focused on using novel biomarkers to improve risk stratification in patients with acute kidney injury and patients at risk or with prevalent chronic kidney disease. He has been continually funded by the NIH over the last decade for multiple biomarker-related projects. He is the co-founder of RenalytixAI.

Maria Rosa Costanzo

MD, FACC

More

Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and the medical director for Advanced Heart Failure at Edward Hospital Center in Illinois. She currently serves on the Board of Directors for the Heart Failure Society of America. In addition, she is a member of several medical societies and a fellow with the American College of Cardiology, American College of Physicians, American Heart Association, and the European Society of Cardiology, and a Gold Member of the Heart Failure Association of the European Society of Cardiology.

Dr. Costanzo has over 250 publications in peer-reviewed journals, book chapters, and manuscripts. She received her medical degree with honors from Facolta’ Di Medicina e Chirurgia dell’ Universita’ di Bologna, Bologna, Italy.

Maria DeVita

MD, FASNF

More

Dr. Maria DeVita is the Chief of the Division of Nephrology Department of Medicine at Lenox Hill Hospital in New York City. She is the training program Director for Nephrology within the Department of Medicine at Lenox Hill Hospital and a Clinical Professor of Medicine at the Zucker Hofstra/Northwell School of Medicine.[/br]

Dr. DeVita is a Fellow of the American Society of Nephrology, active in the American Society of Hypertension with board appointments, and has held leadership appointments in the New York Society of Nephrology. She is a member of the Medical Advisory Board of Kidney and Urologic Foundation of America, the Medical Advisory Board of the National Kidney Foundation of Greater New York, and the National Kidney Foundation.[/br]

Dr. DeVita is recognized as an international authority in adult nephrology and hypertension. Her research and expertise focus on topics including glomerular disease, acute and chronic renal failure, dialysis, hypertension, and fluid management. She has authored/co-authored countless peer-reviewed clinical papers. She serves on the editorial board of several scientific journals and as a peer reviewer for multiple journals. She has lectured worldwide on topics related to nephrology and been named Top Doc in New York Metro and by New York Magazine.

Sitaramesh Emani

MD

More

Dr. Sitaramesh Emani is an Associate Professor of Medicine at the Ohio State University with dual training in both Advanced Heart Failure/Cardiac Transplant as well as Interventional Cardiology. He also serves as the Director of Heart Failure Clinical Research.

Dr. Emani’s interests include device-based therapies for heart failure patients, including mechanical circulatory support, remote monitoring technologies, other implantable technologies, and devices to treat acute heart failure.

Most recently, Dr. Emani is spearheading the Cardiogenic Shock team at OSU.

Aroti Hegde

MD

More

Dr. Aroti Hegde is a nephrologist at MedStar Health. She is certified by the American Board of Internal Medicine, with a subspecialty in Nephrology and by the American Society of Hypertension, as a specialist in clinical hypertension. Dr. Hegde is a member of the American Medical Association, American College of Physicians, American Society of Nephrology, International Society of Nephrology, and the American Society of Hypertension.

Dr. Hegde received her medical degree from Bangalore University in Bangalore, India. She completed her residency at MedStar Washington Hospital Center, where she also served as chief resident in Internal Medicine. Dr. Hegde completed a fellowship in Nephrology at Duke University Medical Center. Among her many achievements, she received the Joe H. Gaskin Excellence In Teaching Award from both the Hospital Center and MedStar Georgetown University Hospital.

Brian Jaski

MD, FACC

More

Dr. Brian Jaski earned undergraduate degrees in electrical engineering and biology at MIT. He graduated from Harvard Medical School where he subsequently went on to do his cardiology fellowship at the Brigham and Women’s Hospital.

Since 1985, Dr. Jaski has been the medical director of the Advanced Heart Failure and Cardiac Transplant Program at Sharp Memorial Hospital associated with the San Diego Cardiac Center.

Dr. Jaski has published in the areas of therapies for decompensated heart failure, circulatory support devices, and cardiac transplant. He is board-certified in the subspecialty of Advanced Heart Failure and Cardiac Transplant.

John Jefferies

MD, MPH, FACC, FHFSA

More

Dr. John Lynn Jefferies is the Jay M. Sullivan Endowed Chair in Cardiovascular Medicine and Chief of Cardiology at the University of Tennessee Health Science Center (UTHSC). He also serves as Co-Director of the Methodist University of Tennessee Cardiovascular Institute and the Methodist Cardiovascular Service Line. Dr. Jefferies is also a Professor of Pediatric Cardiology and a Research Member of St. Jude Children’s Research Hospital.

Dr. Jefferies graduated from the University of Tennessee College of Medicine and did his Residency and Fellowships at the University of Kentucky in Lexington and Baylor College of Medicine in Houston, TX. Prior to joining UT Methodist, he was a Professor at the University of Cincinnati and Cincinnati Children’s Hospital.

Dr. Jefferies has published nearly 250 articles and abstracts on a variety of topics and has authored chapters in over 15 textbooks.

Amir Kazory

MD, FASN, FACC

More

Dr. Amir Kazory is Professor of Medicine and Vice-Chief of Clinical Affairs in the Division of Nephrology, Hypertension, and Renal Transplantation at the University of Florida. His main research interest is the nephrologic aspects of heart failure, disorders of water homeostasis, cardiorenal syndrome, and the interactions between kidney and heart in various pathologic settings.

Dr. Kazory has been involved in clinical research projects including those related to extracorporeal and pharmacologic therapies that are currently offered to patients with cardiorenal syndrome and other disorders of water homeostasis and congestive states. He regularly provides talks on these topics at various national and international conferences in the US and overseas.

Mehdi Oloomi

MD

More

Dr. Mehdi Oloomi has been a Cardiothoracic Intensivist for the last eighteen years. He has been the Medical Director of Cardiothoracic ICU in Maimonides Medical Center, St. Michael’s Medical Center, and most recently at Mount Sinai Medical Center-Main Campus for the past nine years.

Dr. Oloomi is very involved in the concept of cardiac team and closed ICU related to post-op management. His training in Internal Medicine, Pulmonary, and Critical Care Medicine along with his extensive experience provides a unique perspective in the care of cardiothoracic surgery patients.

Dr. Oloomi’s areas of interest include Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Hemostasis/ Coagulopathy. He has been extensively involved in the development of protocols for Renal Replacement Therapy (RRT).

Close
Nestor Jaramillo, Jr.

Nestor Jaramillo, Jr.

President & Chief Executive Officer

Nestor Jaramillo, Jr. has been a key player in medical device commercialization for more than 20 years and has led commercial organizations in both startup and multinational companies.

Prior to joining CHF Solutions, Mr. Jaramillo was president and CEO of Innerspace Neuro Solutions, Inc., a Tustin, Calif.-based commercial-stage medical technology company that developed, manufactured and distributed an intracranial pressure monitoring system.  He also worked in a variety of capacities at startup Transoma Medical, St. Jude Medical, and at Medtronic.

In addition, Mr. Jaramillo also spent seven years as a managing director of healthcare investment banking at both Cherry Tree & Associates and Craig-Hallum Capital, both in Minneapolis.

Mr. Jaramillo holds an electrical engineering degree from the University of North Dakota and a Master of Business Administration from the University of St. Thomas in Minneapolis.

jump